Allogene Therapeutics ALLO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 1.46 | 385 | -14.79 | -60 | -11.31 | 508 |
| 2024Q4 | 2.13 | 422 | -13.53 | -60 | -10.54 | 549 |
| 2024Q3 | 2.80 | 464 | -13.55 | -66 | -10.73 | 589 |
| 2024Q2 | 2.33 | 515 | -13.59 | -66 | -10.76 | 647 |
| 2024Q1 | 4.47 | 461 | -13.35 | -65 | -10.58 | 586 |
| 2023Q4 | 3.21 | 512 | -15.66 | -86 | -12.66 | 643 |
| 2023Q3 | 3.17 | 583 | -9.75 | -59 | -7.93 | 712 |
| 2023Q2 | 4.97 | 623 | -13.04 | -79 | -10.44 | 771 |
| 2023Q1 | 4.94 | 592 | -15.89 | -100 | -12.78 | 747 |
| 2022Q4 | 6.29 | 666 | -13.49 | -95 | -11.13 | 817 |
| 2022Q3 | 10.80 | 740 | -10.79 | -83 | -9.06 | 888 |
| 2022Q2 | 11.40 | 802 | -9.03 | -75 | -7.82 | 948 |
| 2022Q1 | 9.11 | 855 | -9.01 | -80 | -7.97 | 965 |
| 2021Q4 | 14.92 | 916 | -7.94 | -75 | -7.07 | 1,039 |
| 2021Q3 | 25.70 | 970 | -7.84 | -78 | -7.09 | 1,079 |
| 2021Q2 | 26.08 | 1,024 | -6.78 | -71 | -6.15 | 1,127 |
| 2021Q1 | 35.30 | 1,070 | -3.07 | -33 | -2.74 | 1,179 |
| 2020Q4 | 25.24 | 1,080 | -6.24 | -69 | -5.60 | 1,228 |
| 2020Q3 | 37.71 | 1,119 | -5.80 | -66 | -5.34 | 1,223 |
| 2020Q2 | 42.82 | 1,163 | -6.89 | -61 | -6.26 | 1,259 |